Cellegy regulatory update

Cellegy Pharmaceuticals Inc. Cellegy Pharmaceuticals Inc. has received Orphan Drug Designation from the FDA for its monolaurin, a dermatologic compound for the treatment of primary ichthyosis, a disf...